Risks of TNF-α Blockers

October 1, 2003

Montreal - Drugs that block tumor necrosis factor alpha are showing great promise for the treatment of moderate to severe psoriasis, a condition that causes sufferers a good deal of misery and that can be frustratingly resistant to many treatments. However, the high potency comes with a tradeoff. Research indicates that blocking TNF-a may place patients at a higher risk for serious infections, notably tuberculosis.